Finerenone receives positive CHMP opinion for EU-label extension for broad range of patients with chronic kidney disease and type 2 diabetes
Not intended for U.S. and UK Media Berlin, December 16, 2022 – Bayer announced today that the Committee for Medicinal ...
Read more
